IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
German Phase 1 biotech developing an mRNA vaccine for SARS-CoV-2.
Industry: Health Care
Latest Trade: $96.30 +2.00 (+2.1%)
First Day Return: +249.4%
Return from IPO: +489.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 07/24/2020 |
Offer Price | $16.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 13.3 |
Deal Size ($mm) | $213 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 08/13/2020 |
Offer Price | $16.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 13.3 |
Deal Size ($mm) | $213 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
more |
Company Data | |
---|---|
Headquarters | Tübingen, Germany |
Founded | 2000 |
Employees | 484 |
Website www.curevac.com |